| |
 |
Editorial [Hot topic: New Strategies in the Search of Antipsychotic Drugs (Executive Editor: Albert Adell)]
|
| |
|
pp.486-487 (2) Author: Albert Adell
|
| |
|
|
| |
|
Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
|
| |
|
pp.488-501 (14) Authors: Richard B. Mailman, Vishakantha Murthy
|
| |
|
|
| |
|
Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex
|
| |
|
pp.502-515 (14) Authors: Xavier Lopez-Gil, Francesc Artigas, Albert Adell
|
| |
|
|
| |
|
Antipsychotic Medication: The Potential Role of 5-HT1A Receptor Agonism
|
| |
|
pp.516-521 (6) Authors: Andrew C. McCreary, Caitlin A. Jones
|
| |
|
|
| |
|
Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
|
| |
|
pp.522-537 (16) Authors: Guochuan E. Tsai, Pao-Yen Lin
|
| |
|
|
| |
|
Targeting α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia
|
| |
|
pp.538-554 (17) Authors: Mihaly Hajos, Bruce N. Rogers
|
| |
|
|
| |
|
Anti-Infective Strategies of the Future: Is there Room for Species-Specific Antibacterial Agents?
|
| |
|
pp.555-566 (12) Authors: Rudolf L. Then, Hans-Georg Sahl
|
| |
|
|
| |
|
The Synergistic Use of Computation, Chemistry and Biology to Discover Novel Peptide-Based Drugs: The Time is Right
|
| |
|
pp.567-582 (16) Authors: J. Audie, C. Boyd
|
| |
|
|
